首頁 > 市場調查報告書 > 醫療設備

生技設備 3D列印

市場調查報告書

商品編碼

1618309

Bioink 市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

Bioink Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年10月04日 | 出版商:

Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球生物墨水市場價值為7,040 萬美元，預計2024 年至2032 年複合年成長率為12.5%。率上升所推動。對生物列印組織和器官等創新醫療解決方案的需求不斷成長，正在推動市場擴張。 3D 生物列印技術的進步以及製藥公司和研究機構之間合作的加強也有助於市場成長。這些合作關係有助於推動生物墨水配方的創新，並增強其在組織工程和藥物傳輸等領域的應用。

生物列印系統的不斷發展以及生物相容性和多功能性生物墨水的開發預計將進一步加速市場成長。市場根據生物墨水類型分為天然和合成類別。 2023年，天然生物墨水領域以6,070萬美元的收入引領市場。天然生物墨水因其生物相容性和無毒特性而受到青睞，使其適合組織工程應用。

生物醫學研究中對永續實踐的日益重視進一步增加了對天然生物墨水的需求，因為它們通常來自可再生和可生物分解的來源。從材料來看，生物墨水市場包括膠原蛋白、海藻酸鹽、明膠、瓊脂糖、殼聚醣、Pluronic等。膠原蛋白成為主導材料，到 2023 年將佔據 36% 的市場佔有率。膠原蛋白在傷口癒合和組織修復等各種醫療應用中的使用，再加上監管部門的批准，預計將推動該領域的持續成長。。此外，北美受益於鼓勵對生物列印技術投資的支持性監管環境，促進了市場的進一步成長。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	7040 萬美元
預測值	2.021 億美元
複合年成長率	12.5%

產業生態系統分析
產業影響力
- 成長動力
  - 再生醫學中的應用不斷增加
  - 對 3D 列印組織和器官的需求增加
  - 慢性病和器官衰竭盛行率上升
  - 生物列印技術的進步
- 產業陷阱與挑戰
  - 嚴格的核准備案流程
  - 製造成本高
成長潛力分析
監管環境
未來市場趨勢
技術進步
差距分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按類型，2021 - 2032

主要趨勢
天然生物墨水
合成生物墨水

第 6 章：市場估計與預測：按材料分類，2021 - 2032 年

主要趨勢
膠原
海藻酸鹽
明膠
瓊脂糖
殼聚醣
普魯羅尼克
其他材料

第 7 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
組織工程
醫療應用
藥物發現與遞送
其他應用

第 8 章：市場估計與預測：按印刷方式，2021 - 2032 年

主要趨勢
基於擠壓的生物列印
基於噴墨的生物列印
基於雷射的生物列印

第 9 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
製藥和生物技術公司
學術及研究機構
醫院和診所
其他最終用途

第 10 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 11 章：公司簡介

Allevi, Inc. (3D Systems)
Axolotl Biosciences
BIO INX
CELLLINK (BICO)
CollPlant Biotechnologies Ltd
Foldink
Gelomics
INNOREGEN, Inc.
Merck KGaA
Rokit Healthcare
TheWell Bioscience Inc.
UPM Biomedicals
Viscient Biosciences
VoxCell BioInnovation Inc.

簡介目錄

Product Code: 9118

The Global Bioink Market was valued at USD 70.4 million in 2023 and is projected to grow at a CAGR of 12.5% from 2024 to 2032. This rapid growth is primarily driven by the increasing use of bioink in biomedical research therapy and the rising prevalence of chronic diseases and organ failure. The growing demand for innovative medical solutions, such as bio-printed tissues and organs, is fueling the market expansion. Advancements in 3D bioprinting technology, alongside increased collaborations between pharmaceutical companies and research institutions, also contribute to market growth. These partnerships help drive innovations in bioink formulations, enhancing their application in areas like tissue engineering and drug delivery.

The continuous evolution of bioprinting systems and the development of bioinks that are both biocompatible and versatile are expected to further accelerate market growth. The market is segmented based on bioink types into natural and synthetic categories. In 2023, the natural bioink segment led the market with a revenue of USD 60.7 million. Natural bioinks are favored due to their biocompatibility and non-toxic properties, making them suitable for tissue engineering applications.

The increasing emphasis on sustainable practices in biomedical research has further bolstered the demand for natural bioinks, as they are often derived from renewable and biodegradable sources. In terms of materials, the bioink market includes collagen, alginate, gelatin, agarose, chitosan, Pluronic, and others. Collagen emerged as the dominant material, holding a 36% market share in 2023. Its high compatibility with human tissue and its ability to form fibrous networks make collagen essential for tissue engineering and regenerative medicine. The use of collagen in various medical applications, such as wound healing and tissue repair, coupled with regulatory approvals, is expected to drive continued growth in this segment.Regionally, North America accounted for a significant 43.6% of the market in 2023. The availability of advanced bioink technologies, including improved printing resolutions and multi-material capabilities, enhances the adoption of bioink-based products in the region. Furthermore, North America benefits from a supportive regulatory environment encouraging investment in bioprinting technology, fostering further market growth.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$70.4 Million
Forecast Value	$202.1 Million
CAGR	12.5%

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising application in regenerative medicine
  - 3.2.1.2 Increase in demand for 3D printed tissue and organs
  - 3.2.1.3 Rise in prevalence of chronic disease and organ failure
  - 3.2.1.4 Advancement in bioprinting technologies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringent approval filing process
  - 3.2.2.2 High manufacturing cost
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Technological advancements
3.7 GAP analysis
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Natural bioink
5.3 Synthetic bioink

Chapter 6 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Collagen
6.3 Alginate
6.4 Gelatin
6.5 Agarose
6.6 Chitosan
6.7 Pluronic
6.8 Other materials

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Tissue engineering
7.3 Medical application
7.4 Drug discovery & delivery
7.5 Other applications

Chapter 8 Market Estimates and Forecast, By Printing Modality, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Extrusion based bioprinting
8.3 Ink-jet based bioprinting
8.4 Laser-based bioprinting

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 Pharmaceutical & biotechnology companies
9.3 Academic & research institutes
9.4 Hospitals and clinics
9.5 Other End Use

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

10.1 Key trends
10.2 North America
- 10.1.1 U.S.
- 10.1.2 Canada
10.2 Europe
- 10.2.1 Germany
- 10.2.2 UK
- 10.2.3 France
- 10.2.4 Italy
- 10.2.5 Spain
- 10.2.6 Netherlands
- 10.2.7 Rest of Europe
10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 Australia
- 10.3.5 South Korea
- 10.3.6 Rest of Asia Pacific
10.4 Latin America
- 10.4.1 Brazil
- 10.4.2 Mexico
- 10.4.3 Rest of Latin America
10.5 Middle East and Africa
- 10.5.1 South Africa
- 10.5.2 Saudi Arabia
- 10.5.3 UAE
- 10.5.4 Rest of Middle East and Africa